Considerations for standardizing predictive molecular pathology for cancer prognosis

Michelangelo Fiorentino1, Marina Scarpelli2, Antonio Lopez-Beltran3

  • 1a Pathology Service , Addarii Institute of Oncology, S. Orsola-Malpighi Hospital , Bologna , Italy.

Summary

Molecular pathology testing is rapidly advancing, with innovations like massive parallel sequencing poised to replace current methods. Automation and integrated digital workflows are transforming sample analysis and reporting in pathology departments.